%0 Journal Article %A Bernhard Kainz %A Antonios Makropoulos %A Jonas Oppenheimer %A Christopher Deane %A Sven Mischkewitz %A Fouad Al-Noor %A Andrew C Rawdin %A Matthew D Stevenson %A Ramin Mandegaran %A Mattias P. Heinrich %A Nicola Curry %T Non-invasive Diagnosis of Deep Vein Thrombosis from Ultrasound with Machine Learning %D 2021 %R 10.1101/2021.01.23.21249964 %J medRxiv %P 2021.01.23.21249964 %X Deep Vein Thrombosis (DVT) is a blood clot most found in the leg, which can lead to fatal pulmonary embolism (PE). Compression ultrasound of the legs is the diagnostic gold standard, leading to a definitive diagnosis. However, many patients with possible symptoms are not found to have a DVT, resulting in long referral waiting times for patients and a large clinical burden for specialists. Thus, diagnosis at the point of care by non-specialists is desired.We collect images in a pre-clinical study and investigate a deep learning approach for the automatic interpretation of compression ultrasound images. Our method provides guidance for free-hand ultrasound and aids non-specialists in detecting DVT.We train a deep learning algorithm on ultrasound videos from 246 healthy volunteers and evaluate on a sample size of 51 prospectively enrolled patients from an NHS DVT diagnostic clinic. 32 DVT-positive patients and 19 DVT-negative patients were included. Algorithmic DVT diagnosis results in a sensitivity of 93.8% and a specificity of 84.2%, a positive predictive value of 90.9%, and a negative predictive value of 88.9% compared to the clinical gold standard.To assess the potential benefits of this technology in healthcare we evaluate the entire clinical DVT decision algorithm and provide cost analysis when integrating our approach into a diagnostic pathway for DVT. Our approach is estimated to be cost effective at up to $150 per software examination, assuming a willingness to pay $26 000/QALY.Competing Interest StatementB.K., M.H., R.M., and N.C. are scientific advisors for ThinkSono Ldt B.K. is also advisor for Ultromics Ldt And Cydar medical Ldt J.O. acts as a consultant for ThinkSono Ldt. A.M. was an employee of ThinkSono Ldt until September 2020. F.AN., S.M. are employees of ThinkSono Ldt, M.D.S. and A.C.R. acted as contractor for ThinkSono Ldt. All authors had full access to all data during this study and accept responsibility to submit for publication. B.K., A.M., F.AN., S.M. are joint inventors on a patent held by ThinkSono Ldt. The views expressed are those of the author(s) and not necessarily those of ThinkSono, the NHS, the NIHR or the Department of Health.Funding StatementThinkSono Ldt funded the development of the method. Data was collected at Oxford Haemophilia & Thrombosis Centre independently. ThinkSono Ldt provided ultrasound data acquisition devices to Oxford Haemophilia & Thrombosis Centre for this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The University of Oxford, UK, 18/SC/0220, IRAS 234007All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesBeginning 9 months and ending 36 months following article publication in a peer reviewed journal algorithm raw data results access in line with the informed consent of the participants, subject to approval by the project ethics board and under a formal Data Sharing Agreement. Proposals may be submitted up to 36 months following article publication in a peer reviewed journal. Custom computer code is available through ThinkSono Ldt with case specific license agreements. %U https://www.medrxiv.org/content/medrxiv/early/2021/01/27/2021.01.23.21249964.full.pdf